首页> The Journal of clinical investigation> Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers.

Androgen receptor splice variant 7 expression levels distinguish AR-mutated from nonmutated metastatic castration-resistant prostate cancers.

导出 OA

翻译打印收藏纠错

第一作者： Alec,Paschalis

第一单位： The Institute of Cancer Research, London, United Kingdom.;The Royal Marsden Hospital, London, United Kingdom.

作者： Alec,Paschalis ^[1] ; Ines,Figueiredo ^[2] ; Denisa,Bogdan ^[2] ; Arian,Lundberg ^[2] ; Rita,Santos ^[2] ; Bora,Gurel ^[2] ; Tarek,Taha ^[1] ; Ossian,Longoria ^[1] ; Ana,Ferreira ^[2] ; Claudia,Bertan ^[2] ; Nicholas,Brittain ^[3] ; Ryan,Nelson ^[3] ; Laura,Walker ^[3] ; Antje,Neeb ^[2] ; Jonathan,Welti ^[2] ; Wei,Yuan ^[2] ; Costas,Mitsopoulos ^[2] ; Stephen R,Plymate ^[4] ; Michael C,Haffner ^[5] ; Adam G,Sowalsky ^[6] ; Suzanne,Carreira ^[2] ; Adam,Sharp ^[1] ; Luke,Gaughan ^[3] ; Johann,de Bono ^[1]

作者单位： The Institute of Cancer Research, London, United Kingdom.;The Royal Marsden Hospital, London, United Kingdom. ^[1] The Institute of Cancer Research, London, United Kingdom. ^[2] Newcastle University Centre for Cancer, United Kingdom. ^[3] Department of Medicine, University of Washington School of Medicine and VAPSHCS-GRECC, Seattle, Washington, USA. ^[4] Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center, Seattle, Washington, USA.;Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. ^[5] Genitourinary Malignancies Branch, National Cancer Institute, Bethesda, Maryland, USA. ^[6]

关键词 Clinical Research Oncology Prostate cancer